CROSS REFERENCE TO RELATED APPLICATIONS
This application is a National Stage of International Application No. PCT/EP2008/052739 filed Mar. 6, 2008 the contents of all of which are incorporated herein by reference in their entirety.
The present invention is directed to novel 2-aryl and
CROSS-REFERENCE TO RELATED APPLICATIONS
This application claims priority to copending U.S. patent application Ser. No. 10/634,463, filed Aug. 4, 2003, which claims priority to U.S. Provisional Patent Application No. 60/400,742, filed Aug. 2, 2002, the entirety of which is incorporated herein by
FIELD OF THE INVENTION
The present invention relates to compounds, particularly 2-heterosubstituted 3-aryl-4H-benzopyran-4-ones, for treating or preventing cancer in a mammalian subject and methods of making and using such 2-heterosubstituted 3-aryl-4H-benzopyran-4-ones.
BACKGROUND OF THE
BACKGROUND OF THE INVENTION
The use of light in the treatment of various skin diseases has been around for centuries. This field termed phototherapy uses a combination of small molecules that can absorb light in the visible, UV-A, and near-infrared range. Phototherapy is comparable to radiotherapy
BACKGROUND OF THE INVENTION
The use of light in the treatment of various skin diseases has been around for centuries. This field termed phototherapy uses a combination of small molecules that can absorb light in the visible, UV-A, and near-infrared range. Phototherapy is comparable to radiotherapy
FIELD
Disclosed herein are methods and pharmaceutical compositions for treating proliferative disorders and for suppressing an immune system response that involve administering certain 4H-1-benzopyran-4-one compounds to a subject.
BACKGROUND
Phosphatidylinositol 3-kinases (PI3K) phosphorylate
اكتب أحد الأعراض أو المرض واقرأ عن الأعشاب التي قد تساعد ، واكتب عشبًا واطلع على الأمراض والأعراض التي تستخدم ضدها. * تستند جميع المعلومات إلى البحوث العلمية المنشورة